Orange Book product · Brand (NDA)

TOVIAZ

FESOTERODINE FUMARATE

Brand (NDA)NDA 022030TE ABRX PFIZER

Oct 31, 2008

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Oct 31, 2008
17 yr 11 mo ago
Today
Patent 7807715 expires
Listed drug product patent expiration.
Jun 07, 2027
in 1 yr
Patent 8088398 expires
Listed drug product patent expiration.
Jun 07, 2027
in 1 yr
Patent 8501723 expires
Listed drug product patent expiration.
Jun 07, 2027
in 1 yr
Patent 7807715*PED expires
Listed listed patent expiration.
Dec 07, 2027
in 1 yr 6 mo
Patent 8088398*PED expires
Listed listed patent expiration.
Dec 07, 2027
in 1 yr 6 mo
Patent 8501723*PED expires
Listed listed patent expiration.
Dec 07, 2027
in 1 yr 6 mo

Active ingredient

FESOTERODINE FUMARATE

Strength

4MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Application

NDA 022030

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7807715	Jun 07, 2027	in 1 yr	ProductU-913
8088398	Jun 07, 2027	in 1 yr	ProductU-913
8501723	Jun 07, 2027	in 1 yr	Product
7807715*PED	Dec 07, 2027	in 1 yr 6 mo
8088398*PED	Dec 07, 2027	in 1 yr 6 mo
8501723*PED	Dec 07, 2027	in 1 yr 6 mo